
Lakeshore Cancer Center
@lakeshorecancer
Cancer Treatment | Cancer Diagnostics | Molecular Pathology | Cancer Genomics | Cancer Genetic Testing | Cancer Research
ID: 1488961173877837829
02-02-2022 19:43:52
43 Tweet
27 Followers
98 Following






Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer Annals of Oncology annalsofoncology.org/article/S0923-…


Thank you Lakeshore Cancer Center On behalf of the children, we say thank you for your support and donation. Thank you #ChildrenareGold #lakeshorecancercenter #thedorcascancerfoundation #childhoodcancernigeria #goldseptember #cancerclinic #cancerdoctor #pediatriccancer


#SITC22 I am delighted to introduce to you STAR0602, a novel, bispecific T-cell receptor (TCR) agonist antibody that selectively targets and activates a subset of Vβ T-cells. It has just been cleared for a clinical trial (NCT05592626) that we plan to open at National Cancer Institute.



MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis ACS Journal Cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…



1 in 2 people will get cancer in their lifetime and all of us can support the research that will beat it. So this Christmas sign up to Swimathon 2023 and take part to support Cancer Research UK's life-saving research 👉limelig.ht/3v3


